A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Healthy

Interventions

DRUG

Darunavir

Darunavir ethanolate will be administered as single oral dosing of two tablets of 300 milligram (mg) on Day 3.

DRUG

Ritonavir

Ritonavir capsule will be administered orally twice daily at a dose of 100 mg for 5 days.

Trial Locations (1)

Tsukuba